Clinical Trial Update: Bone Resorption, Osteoclastogenesis and Adalimumab [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating bone resorption and osteoclastogenesis in rheumatoid arthritis patients treated with adalimumab.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Université de Sherbrooke | Conditions: RheumatoId Arthritis | Phase 4 | Status: UNKNOWN